Table 1 (abstract P441). Demographic and clinical characteristics of children and adolescents with JIA
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Variables | N = 26 | Oral MTX N = 9 | Subcutaneous MTX N = 6 |
|---|---|---|---|
Female N (%) | 17 (65.4) | 4 (44.4) | 5 (83.3) |
Age (mean ± SD) years | 11.9 ± 0.8 | 10.9 ± 1.7 | 12.2 ± 1.4 |
Disease duration (mean ± SD) years | 7.5 ± 0.8 | 7.6 ± 1.4 | 10.8 ± 1.5 |
JIA ILAR category N (%) | |||
 Persistent oligoarticular arthritis | 8 (30.8) | 3 (33.3) | 2 (33.3) |
 Extended oligoarticular arthritis | 8 (30.8) | 2 (22.2) | 4 (66.7) |
 JADAS | 1.3 (4.9) | 2 (7.3) | 1 (5.3) |
 ESR mm/h/ CRP mg/dL | 11 (9)/0.06 (0.15) | 11 (12)/0.06 (0.2) | 8 (12)/0.06 (0.3) |
 Swollen/ tender joints | 0/0 | 0/0 | 0/0 |